Prosecution Insights
Last updated: April 19, 2026

Emendobio Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
4
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17625290 DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF RPE65 JOHNSON, ALLISON MARIE 1638 Final Rejection Jan 06, 2022
17607690 NOVEL OMNI CRISPR NUCLEASES ALLEN, SARAH ELIZABETH 1637 Final Rejection Oct 29, 2021
17433977 DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF STAT1 KONOPKA, CATHERINE ANNE 1635 Final Rejection Aug 25, 2021
17420934 CRISPR COMPOSITIONS AND METHODS FOR PROMOTING GENE EDITING OF ADENOSINE DEAMINASE 2 (ADA2) TRAN, CHRISTINA L 1637 Final Rejection Jul 06, 2021
16202955 DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS RHODOPSIN GENE SHIN, DANA H 1635 Non-Final OA Nov 28, 2018

Managing Emendobio Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month